ATLANTA – Atlanta Braves outfielder Jurickson Profar has been suspended for the entire 2026 Major League Baseball season after testing positive for a performance-enhancing substance. The suspension, totaling 162 games, marks the second time Profar has violated MLB’s Joint Drug Prevention and Treatment Program, triggering the maximum penalty. The news casts a significant shadow over the Braves’ early season outlook and raises questions about the team’s offensive depth.
The announcement comes as a blow to the Braves, who were counting on Profar to contribute in a versatile role. He was expected to observe time in both the outfield and at designated hitter. Profar, 31, had been a key part of the Braves’ roster, providing a switch-hitting option and solid defensive play. The suspension immediately impacts the team’s plans for the upcoming season, forcing them to reassess their roster construction and potentially seek external options to fill the void.
Second PED Violation Leads to Lengthy Ban
According to MLB.com, the 162-game suspension is the standard penalty for a second positive PED test. MLB.com reported that details surrounding the specific substance involved have not been publicly disclosed. This is not Profar’s first encounter with a PED-related suspension; he received an 80-game suspension in 2020 while a member of the Texas Rangers for a similar violation. The repeat offense has resulted in the significantly harsher penalty.
Braves Respond to the Suspension
The Braves organization released a statement expressing their disappointment with the news. While the official statement did not include specific details, it conveyed the team’s commitment to upholding the integrity of the game. Sports Illustrated reported that team officials were “incredibly disappointed” by the development. The suspension leaves a hole in the Braves’ lineup and forces manager Brian Snitker to adjust his plans for the season.
Impact on the Braves’ Season
Profar’s absence will undoubtedly be felt throughout the Braves’ lineup. In 2025, he batted .236 with 15 home runs and 58 RBIs in 143 games. His versatility allowed him to play multiple positions, providing Snitker with valuable flexibility. The Braves will now demand to rely on other players to step up and fill the void, potentially giving opportunities to younger players within the organization. The team may also explore trade options or free agent signings to bolster their outfield depth. Battery Power discussed the potential impact on the team’s overall performance.
The suspension also raises questions about the effectiveness of MLB’s drug testing program. While the program has been revised several times over the years, positive tests continue to occur, highlighting the ongoing challenge of combating PED use in baseball. The Braves, like other teams, will likely emphasize the importance of clean play and adherence to MLB’s policies.
What comes next for the Braves is a period of adjustment and evaluation. The team will need to identify internal and external options to replace Profar’s production and versatility. The focus will shift to ensuring the remaining players are prepared to step up and contribute to the team’s success. The situation serves as a stark reminder of the consequences of violating MLB’s drug policies and the importance of maintaining the integrity of the game.
Share your thoughts on this developing story in the comments below. We encourage a respectful discussion about the impact of this suspension on the Braves and the broader issue of PEDs in baseball.